Last reviewed · How we verify

NCT05694208

The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life

Recruiting now NA Last updated 15 November 2024
What this trial tests

NA trial testing Education Group in Gynecologic Cancer in 84 participants. Currently enrolling.

Timeline
1 February 2023
Primary endpoint
30 December 2024
1 January 2025

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment84
Start date1 February 2023
Primary completion30 December 2024
Estimated completion1 January 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

18 and older, female only, with Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned in a randomized controlled prospective experimental design in order to determine the effect of mobile-based education given to patients undergoing gynecological oncology surgery on quality of life. Research Hypotheses: H1. Education given with mobile application in gynecological oncology patients positively affects symptom control of patients. H2. The education given with the mobile application in gynecological oncology patients positively affects the quality of life of the patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Education Group

Trials testing the same drug.

Other recruiting trials for Gynecologic Cancer

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05694208.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing